Advertisement
EXEL vs PDFS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EXEL is a StrongBuy and PDFS is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EXEL’s FA Score shows that 1 FA rating(s) are green whilePDFS’s FA Score has 1 green FA rating(s).
- EXEL’s FA Score: 1 green, 4 red.
- PDFS’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EXEL’s TA Score shows that 5 TA indicator(s) are bullish while PDFS’s TA Score has 5 bullish TA indicator(s).
- EXEL’s TA Score: 5 bullish, 5 bearish.
- PDFS’s TA Score: 5 bullish, 4 bearish.
Price Growth
EXEL (@Biotechnology) experienced а +0.37% price change this week, while PDFS (@Packaged Software) price change was +1.38% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +17.87%, and the average quarterly price growth was +32.70%.
The average weekly price growth across all stocks in the @Packaged Software industry was +2.23%. For the same industry, the average monthly price growth was -0.63%, and the average quarterly price growth was +26.71%.
Reported Earning Dates
EXEL is expected to report earnings on Nov 04, 2025.
PDFS is expected to report earnings on Nov 06, 2025.
Industries' Descriptions
@Biotechnology (+4.22% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Packaged Software (+2.23% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
| EXEL | PDFS | EXEL / PDFS | |
| Capitalization | 10.2B | 786M | 1,298% |
| EBITDA | 782M | 5.74M | 13,617% |
| Gain YTD | 13.814 | -26.551 | -52% |
| P/E Ratio | 18.22 | 994.50 | 2% |
| Revenue | 2.23B | 196M | 1,138% |
| Total Cash | 791M | 40.4M | 1,958% |
| Total Debt | 180M | 74M | 243% |
EXEL | PDFS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 59 | 54 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 69 Overvalued | 96 Overvalued | |
PROFIT vs RISK RATING 1..100 | 39 | 98 | |
SMR RATING 1..100 | 33 | 91 | |
PRICE GROWTH RATING 1..100 | 59 | 64 | |
P/E GROWTH RATING 1..100 | 75 | 5 | |
SEASONALITY SCORE 1..100 | n/a | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
EXEL's Valuation (69) in the Biotechnology industry is in the same range as PDFS (96) in the Electronic Production Equipment industry. This means that EXEL’s stock grew similarly to PDFS’s over the last 12 months.
EXEL's Profit vs Risk Rating (39) in the Biotechnology industry is somewhat better than the same rating for PDFS (98) in the Electronic Production Equipment industry. This means that EXEL’s stock grew somewhat faster than PDFS’s over the last 12 months.
EXEL's SMR Rating (33) in the Biotechnology industry is somewhat better than the same rating for PDFS (91) in the Electronic Production Equipment industry. This means that EXEL’s stock grew somewhat faster than PDFS’s over the last 12 months.
EXEL's Price Growth Rating (59) in the Biotechnology industry is in the same range as PDFS (64) in the Electronic Production Equipment industry. This means that EXEL’s stock grew similarly to PDFS’s over the last 12 months.
PDFS's P/E Growth Rating (5) in the Electronic Production Equipment industry is significantly better than the same rating for EXEL (75) in the Biotechnology industry. This means that PDFS’s stock grew significantly faster than EXEL’s over the last 12 months.
| EXEL | PDFS | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 75% | 2 days ago 79% |
| Stochastic ODDS (%) | 2 days ago 51% | 2 days ago 71% |
| Momentum ODDS (%) | 2 days ago 67% | 2 days ago 70% |
| MACD ODDS (%) | 2 days ago 75% | 6 days ago 77% |
| TrendWeek ODDS (%) | 2 days ago 66% | 2 days ago 73% |
| TrendMonth ODDS (%) | 2 days ago 58% | 2 days ago 73% |
| Advances ODDS (%) | 6 days ago 65% | N/A |
| Declines ODDS (%) | 2 days ago 62% | 6 days ago 70% |
| BollingerBands ODDS (%) | 2 days ago 78% | 2 days ago 81% |
| Aroon ODDS (%) | 2 days ago 52% | 2 days ago 73% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| FOREX / NAME | Price $ | Chg $ | Chg % |
| NZDGBP | 0.43 | N/A | N/A |
| New Zealand Dollar - United Kingdom Pound | |||
| NSNCX | 48.58 | N/A | N/A |
| Neuberger Berman Small Cap Growth C | |||
| TRWIX | 25.37 | N/A | N/A |
| Transamerica International Equity I2 | |||
| LSAGX | 23.97 | N/A | N/A |
| Loomis Sayles Global Growth A | |||
| CLGPX | 17.78 | N/A | N/A |
| Columbia Large Cap Growth Opp R | |||
EXEL and
Correlation & Price change
A.I.dvisor indicates that over the last year, EXEL has been loosely correlated with JAZZ. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if EXEL jumps, then JAZZ could also see price increases.
| Ticker / NAME | Correlation To EXEL | 1D Price Change % | ||
|---|---|---|---|---|
| EXEL | 100% | -1.89% | ||
| JAZZ - EXEL | 35% Loosely correlated | +1.20% | ||
| TECH - EXEL | 33% Poorly correlated | -0.67% | ||
| MRSN - EXEL | 32% Poorly correlated | -1.29% | ||
| ORMP - EXEL | 32% Poorly correlated | +1.40% | ||
| AXON - EXEL | 31% Poorly correlated | -0.35% | ||
More | ||||